TrademarkDir
QUALLENT PHARMACEUTICALS
LIVE

Serial Number

90628728

Owner

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.

Attorney

Troy E. Larson

First Use Date

Nov 15, 2021

Filing Date

Apr 7, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

QUALLENT PHARMACEUTICALS Trademark

Serial Number: 90628728 • Registration: 6997500

QUALLENT PHARMACEUTICALS is a trademark filed by EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. on April 7, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (291 trademarks)

ONE EXPRESS WAY
ST. LOUIS, MO 63121

Entity Type: 03

Trademark Details

Filing Date

April 7, 2021

Registration Date

March 7, 2023

First Use Anywhere

November 15, 2021

First Use in Commerce

November 15, 2021

Published for Opposition

May 24, 2022

Goods & Services

Pharmaceutical preparations for use in treating human diseases, namely, the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutraceuticals for use as human dietary supplements; and health food supplements for use in treating human dietary deficiencies

Wholesale distributorship services featuring pharmaceutical preparations for use in treating human diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 7, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 7, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 2, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 1, 2023 CNPR
SOU TEAS EXTENSION RECEIVED
Jan 19, 2023 EEXT
STATEMENT OF USE PROCESSING COMPLETE
Jan 19, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 19, 2023 AITU
USE AMENDMENT FILED
Dec 15, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 15, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 19, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 24, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 24, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 4, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 19, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 14, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 15, 2021 GNRN
NON-FINAL ACTION E-MAILED
Nov 15, 2021 GNRT
NON-FINAL ACTION WRITTEN
Nov 15, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2021 NWOS
NEW APPLICATION ENTERED
Apr 10, 2021 NWAP

Related Trademarks

More from this Owner

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

ONCOLOGY CARE VALUE

ONCOLOGY CARE VALUE

ONCOLOGY CARE VALUE

ONCOLOGY CARE VALUE

ONCOLOGY CARE VALUE

ONCOLOGY CARE VALUE